Navigation Links
SkinMedica Launches TNS Essential Serum(TM)
Date:11/6/2008

-Combines TNS Recovery Complex(R) and APS Corrective Complex(TM)- -97% of Clinical Study Participants Saw Improvements in Skin Elasticity-

CARLSBAD, Calif., Nov. 6 /PRNewswire/ -- SkinMedica, Inc., today announced the recent launch of TNS Essential Serum(TM) a revolutionary anti-aging treatment with a clinically-proven combination of two cutting-edge treatments, TNS Recovery Complex(R) and APS Corrective Complex(TM).

(Photo: http://www.newscom.com/cgi-bin/prnh/20081106/LATH037)

TNS Recovery Complex has been shown to rejuvenate sun damaged and aging skin. It contains the key active ingredient NouriCel-MD(R), a patented blend of growth factors, soluble collagen, antioxidants and matrix proteins. APS Corrective Complex is a potent mixture of three novel peptides and seven antioxidants and other innovative anti-aging ingredients. Combined in TNS Essential Serum, these two formulas work in synergy to transform and regenerate skin for a more youthful, glowing appearance.

"TNS Essential Serum is an unprecedented combination," stated Richard Fitzpatrick, MD, the founder of SkinMedica. "This formulation marries the potent growth factor serum in TNS Recovery Complex with the protective, antioxidant properties of APS Corrective Complex, providing our customers with comprehensive anti-aging care and protection. SkinMedica continues to deliver on its commitment to physicians and consumers to use leading-edge science to develop the most advanced, professional skin-care products available today."

Statistically Significant Clinical Study Results

In a recent clinical study, 37 women aged 32 - 55 with mild-to-severe wrinkling used TNS Essential Serum twice-daily for three months. Study participants were evaluated monthly, using physician assessments, digital photography and patient self-assessment. 97% saw improvements in the elasticity of their skin and 92% rated their skin as looking healthier and more youthful. In addition, TNS Essential Serum demonstrated statistically significant improvements in the following physician-evaluated clinical endpoints:

-- Textural roughness

-- Fine and coarse wrinkles

-- Skin radiance and elasticity

-- Protection from UV exposure and resulting skin damage

TNS Essential Serum is available exclusively at doctor's offices and medically supervised spas. Visit http://www.skinmedica.com to find a location.

About SkinMedica

SkinMedica is a privately held specialty company marketing both prescription and aesthetic products that improve the appearance of skin and treat dermatologic conditions and diseases. SkinMedica's Desonate(R) (desonide) Gel 0.05% is indicated for the treatment of mild-to-moderate atopic dermatitis; EpiQuin(R) Micro (4% hydroquinone) cream is indicated for melasma and postinflammatory hyperpigmentation; VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the treatment of unwanted facial hair in women; and NeoBenz(R) Micro Cream and NeoBenz(R) Micro SD (single dose) are the only benzoyl peroxide prescription products that contain a patented gradual-release formulation of benzoyl peroxide to treat acne. The company's full line of clinical skin care products, which is sold through physicians, includes TNS Recovery Complex(R) with NouriCel-MD(R) to help improve the health and appearance of aging skin. SkinMedica is based in Carlsbad, California. For more information, visit http://www.skinmedica.com.

SkinMedica(R), Desonate(R), EpiQuin(R) Micro, NeoBenz(R) Micro, NouriCel-MD(R), TNS Recovery Complex(R), and VANIQA(R) are registered trademarks of SkinMedica, Inc.

CONTACT INFORMATION:

Erin McNally

Shop PR

(212) 829-1111 x192

erin@shop-pr.com

http://www.skinmedica.com


'/>"/>
SOURCE SkinMedica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Genesis Pharmaceuticals Launches New Corporate Website
2. Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent
3. HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City
4. Mattel Childrens Hospital UCLA launches program in nanopediatrics
5. DNA2.0 Launches New Website: Enhanced Design and Free Bioinformatics Tools Demonstrate DNA2.0's Customer Focus
6. WeissComm Launches Invigorate Communications to Help Companies Build Successful Health-Based Brands
7. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
8. MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position
9. Finesse Solutions Launches TruBio 3.4 Bioreactor Control Software
10. Finesse Solutions Launches Improved E-Store for Sensors and Transmitters
11. Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 2017 , ... As part of the Stago EdVantage Virtual University ... DIC in order to illuminate this clinical problem for people unfamiliar with the topic. ... in a high degree of morbidity and mortality. DIC is a confusing disorder from ...
(Date:4/25/2017)... April 25, 2017 Providence ... licensed its novel immune-modulating technology to an undisclosed global ... allergy. Tregitopes, pronounced T·rej·itopes, are a ... by EpiVax CEO Annie De Groot ... immunoglobulin G, an autoimmune disease therapy, Tregitopes are ...
(Date:4/25/2017)... ... April 25, 2017 , ... Leaders of Quorum Review ... be featured in multiple sessions at this week’s Association of Clinical Research Professionals ... best practices in clinical research. , "We are excited to present subject matter expertise ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... recognized outstanding manufactures in 10 categories with over 30 nominees and well as ... Manufacturing presented the new award and the event was hosted by CompanyWeek and ...
Breaking Biology Technology:
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/29/2017)... CHICAGO , March 29, 2017  higi, the ... ecosystem in North America , today ... Partners and the acquisition of EveryMove. The new investment ... extensive set of tools to transform population health activities ... and lifestyle data. higi collects and secures ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):